The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, Y.
Right arrow Articles by Yin, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, Y.
Right arrow Articles by Yin, Z.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2005, 175: 5783-5789.
Copyright © 2005 by The American Association of Immunologists

JNK1 Is Essential for CD8+ T Cell-Mediated Tumor Immune Surveillance1

Yunfei Gao*, Jian Tao*, Ming O. Li{dagger}, Dongqing Zhang*, Hongbo Chi{dagger}, Octavian Henegariu{dagger}, Susan M. Kaech{dagger}, Roger J. Davis{ddagger}, Richard A. Flavell{dagger} and Zhinan Yin2,*,§

* Section of Rheumatology, Department of Medicine, and {dagger} Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520; {ddagger} University of Massachusetts Medical School, Worcester, MA 01605; and § Immunology Division, E-Institute of Shanghai University, Shanghai, People’s Republic of China

JNK1 has divergent roles in regulating the effector functions of CD4+ and CD8+ T cells. However, the function of JNK1 in tumor immune surveillance is unknown. In this study, we show that similar to IFN-{gamma}–/– mice, JNK1–/– mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4. Using T cell depletion and reconstitution approaches, we show that CD8+ T cells, but not CD4+ T cells, from JNK1–/– mice are responsible for tumor susceptibility. JNK1–/– CD8+ T cells have an intrinsic defect in early IFN-{gamma} gene transcription and production after activation by either anti-CD3/anti-CD28 Abs or dendritic cells loaded with specific Ag in vitro. The impaired IFN-{gamma} production in JNK1–/– CD8+ T cells is associated with reduced expression of both T-bet and Eomesodermin, indicating that JNK1 regulates the transcription program of CD8+ T cells. Finally, JNK1–/– CD8+ T cells showed reduced perforin expression and impaired CTL function. Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.


Related articles in The JI:

IN THIS ISSUE

The JI 2005 175: 5565-5566. [Full Text]  



This article has been cited by other articles:


Home page
FASEB J.Home page
B. Mattioli, E. Straface, P. Matarrese, M. G. Quaranta, L. Giordani, W. Malorni, and M. Viora
Leptin as an immunological adjuvant: enhanced migratory and CD8+ T cell stimulatory capacity of human dendritic cells exposed to leptin
FASEB J, June 1, 2008; 22(6): 2012 - 2022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Tong, Z. Yin, Z. Song, A. Dockendorff, C. Huang, J. Mariadason, R. A. Flavell, R. J. Davis, L. H. Augenlicht, and W. Yang
c-Jun NH2-Terminal Kinase 1 Plays a Critical Role in Intestinal Homeostasis and Tumor Suppression
Am. J. Pathol., July 1, 2007; 171(1): 297 - 303.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Chen, W. He, S. T. Kim, J. Tao, Y. Gao, H. Chi, A. M. Intlekofer, B. Harvey, S. L. Reiner, Z. Yin, et al.
Epigenetic and Transcriptional Programs Lead to Default IFN-{gamma} Production by {gamma}{delta} T Cells
J. Immunol., March 1, 2007; 178(5): 2730 - 2736.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.